Is [ Cancer mortality in France : the number of deaths increasing but the risk of dying from cancer is decreasing ]?
It is a mistake to describe the increase in the number of cancer deaths as worrisome when it is due only to demographic changes. The risk of dying from cancer is not rising in France: it is clearly falling.
This study provides the novel insight that MTX treatment in JIA does not attenuate Teff function but, conversely, enhances T cell proliferation and IFN-γ plasma concentrations in JIA patients.